Interestingly, like RUNX1, exogenous expression of RUNX3 has the ability to increase the expression of ARF, p53, and p21, indicating that RUNX3 is considered as an upstream regulator of the p53 tumor suppressor network [84]. Here, CDKN2A is linked to neoplasm.